FDA
approval
· 2022-01-14
FDA Approved: CIBINQO — Original Application (U.S. Pharmaceuticals)
Summary
FDA approved CIBINQO (abrocitinib) through an original New Drug Application from U.S. Pharmaceuticals. It is indicated for the treatment of moderate-to-severe a…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for CIBINQO (ABROCITINIB)